Carcinoma of the extrahepatic biliary tract: surgery and radiotherapy for curative and palliative intent.

R A Zlotecki, L A Jung, J N Vauthey, S B Vogel, W M Mendenhall
{"title":"Carcinoma of the extrahepatic biliary tract: surgery and radiotherapy for curative and palliative intent.","authors":"R A Zlotecki,&nbsp;L A Jung,&nbsp;J N Vauthey,&nbsp;S B Vogel,&nbsp;W M Mendenhall","doi":"10.1002/(SICI)1520-6823(1998)6:5<240::AID-ROI6>3.0.CO;2-R","DOIUrl":null,"url":null,"abstract":"<p><p>Forty-seven patients were treated for carcinoma of the extrahepatic biliary tract between 1962 and 1993: 17 by surgery alone, 20 by surgery and postoperative radiotherapy, and 10 with radiotherapy alone. Initial operations included gross total resection (17 patients), simple cholecystectomy (6 patients), subtotal resection (11 patients), biopsy (3 patients), and percutaneous decompression (10 patients). External-beam radiotherapy (30-60 Gy) was administered to 30 patients: 10 after gross total resection or simple cholecystectomy, 10 after subtotal resection or surgical biopsy, and 10 after percutaneous decompression. Overall survival was 26% at 3 years and 15% at 5 years. The 5-year survival rate was 15% for 17 patients treated by surgery alone and 14% for 30 patients treated with radiotherapy alone or following surgery. After gross total resection, median survival time was 26.1 months for 9 patients treated by surgery alone vs. 43.4 months for 8 patients who received postoperative radiotherapy. After gross total resection or cholecystectomy, 5-year survival rates were 19% for surgery alone and 35% for surgery and postoperative radiotherapy (P=.07). Median survival for 10 patients treated by radiation therapy alone after percutaneous decompression was 6.4 months. Postoperative adjuvant radiotherapy was well tolerated and may improve local-regional control after gross total resection.</p>","PeriodicalId":20894,"journal":{"name":"Radiation oncology investigations","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1520-6823(1998)6:5<240::AID-ROI6>3.0.CO;2-R","citationCount":"21","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation oncology investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/(SICI)1520-6823(1998)6:5<240::AID-ROI6>3.0.CO;2-R","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 21

Abstract

Forty-seven patients were treated for carcinoma of the extrahepatic biliary tract between 1962 and 1993: 17 by surgery alone, 20 by surgery and postoperative radiotherapy, and 10 with radiotherapy alone. Initial operations included gross total resection (17 patients), simple cholecystectomy (6 patients), subtotal resection (11 patients), biopsy (3 patients), and percutaneous decompression (10 patients). External-beam radiotherapy (30-60 Gy) was administered to 30 patients: 10 after gross total resection or simple cholecystectomy, 10 after subtotal resection or surgical biopsy, and 10 after percutaneous decompression. Overall survival was 26% at 3 years and 15% at 5 years. The 5-year survival rate was 15% for 17 patients treated by surgery alone and 14% for 30 patients treated with radiotherapy alone or following surgery. After gross total resection, median survival time was 26.1 months for 9 patients treated by surgery alone vs. 43.4 months for 8 patients who received postoperative radiotherapy. After gross total resection or cholecystectomy, 5-year survival rates were 19% for surgery alone and 35% for surgery and postoperative radiotherapy (P=.07). Median survival for 10 patients treated by radiation therapy alone after percutaneous decompression was 6.4 months. Postoperative adjuvant radiotherapy was well tolerated and may improve local-regional control after gross total resection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝外胆道癌:手术和放疗治疗和姑息目的。
在1962年至1993年间,47例肝外胆道癌患者接受了治疗:17例单纯手术治疗,20例手术加术后放疗治疗,10例单纯放疗治疗。初始手术包括大体全切除(17例)、单纯胆囊切除术(6例)、次全切除(11例)、活检(3例)和经皮减压(10例)。对30例患者进行外束放疗(30-60 Gy),其中10例在胆囊全切除或单纯切除后,10例在胆囊次全切除或手术活检后,10例在经皮减压后。3年和5年的总生存率分别为26%和15%。单纯手术治疗17例,5年生存率为15%,单纯放疗或术后治疗30例,5年生存率为14%。总切除后,单纯手术治疗的9例患者中位生存时间为26.1个月,而术后放疗的8例患者中位生存时间为43.4个月。粗全切除或胆囊切除术后,单纯手术组5年生存率为19%,手术加术后放疗组5年生存率为35% (P= 0.07)。10例患者经皮减压后单独放疗的中位生存期为6.4个月。术后辅助放疗耐受性良好,可改善全切除后局部区域的控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Molecular and anatomic considerations in the pathogenesis of breast cancer. Telomeric length in individuals and cell lines with altered p53 status. Effect of combined adoptive immunotherapy and radiotherapy on tumor growth. PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1